Development of major depression after treatment for smoking cessation

Janice Y. Tsoh, Gary L. Humfleet, Ricardo F. Muñoz, Victor I. Reus, Diane T. Hartz, Sharon M. Hall

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

Objective: Case studies suggest cigarette abstinence may precipitate a major depressive episode. This study examined the incidence and predictors of major depression in the 12 months after treatment for smoking cessation. Method: Participants (N=304, 172 women) were recruited from two trials of smoking cessation. Both trials provided psychological group intervention, but one group received treatment with nicotine gum and the other was given nortriptyline or placebo. The incidence of major depressive episodes was identified by the Inventory to Diagnose Depression, which was administered at follow-up assessments. Results: The 12-month incidence of major depression after treatment for smoking cessation was 14.1% (N=43). Multiple logistic regression analyses indicated that history of depression, baseline Beck Depression Inventory score, college education, and age at smoking initiation were significant predictors of major depression after treatment. Abstinence at the end of treatment did not significantly predict major depression. Conclusions: Patients who achieved abstinence from smoking showed a risk of developing depressive episodes similar to those who failed to achieve abstinence. As expected, patients who had a history of depression were more likely to experience depressive episodes after treatment for smoking cessation. The 12-month incidence of major depression in this study group was higher than that observed in the general population, but reasons for the elevation were not clear.

Original languageEnglish (US)
Pages (from-to)368-374
Number of pages7
JournalAmerican Journal of Psychiatry
Volume157
Issue number3
DOIs
StatePublished - Mar 2000

Fingerprint

Smoking Cessation
Depression
Therapeutics
Incidence
Smoking
Nortriptyline
Equipment and Supplies
Nicotine
Tobacco Products
Cohort Studies
Logistic Models
Placebos
Regression Analysis
Psychology
Education

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Tsoh, J. Y., Humfleet, G. L., Muñoz, R. F., Reus, V. I., Hartz, D. T., & Hall, S. M. (2000). Development of major depression after treatment for smoking cessation. American Journal of Psychiatry, 157(3), 368-374. https://doi.org/10.1176/appi.ajp.157.3.368

Development of major depression after treatment for smoking cessation. / Tsoh, Janice Y.; Humfleet, Gary L.; Muñoz, Ricardo F.; Reus, Victor I.; Hartz, Diane T.; Hall, Sharon M.

In: American Journal of Psychiatry, Vol. 157, No. 3, 03.2000, p. 368-374.

Research output: Contribution to journalArticle

Tsoh, JY, Humfleet, GL, Muñoz, RF, Reus, VI, Hartz, DT & Hall, SM 2000, 'Development of major depression after treatment for smoking cessation', American Journal of Psychiatry, vol. 157, no. 3, pp. 368-374. https://doi.org/10.1176/appi.ajp.157.3.368
Tsoh, Janice Y. ; Humfleet, Gary L. ; Muñoz, Ricardo F. ; Reus, Victor I. ; Hartz, Diane T. ; Hall, Sharon M. / Development of major depression after treatment for smoking cessation. In: American Journal of Psychiatry. 2000 ; Vol. 157, No. 3. pp. 368-374.
@article{e2447e62c12349dcb2892df0493efa78,
title = "Development of major depression after treatment for smoking cessation",
abstract = "Objective: Case studies suggest cigarette abstinence may precipitate a major depressive episode. This study examined the incidence and predictors of major depression in the 12 months after treatment for smoking cessation. Method: Participants (N=304, 172 women) were recruited from two trials of smoking cessation. Both trials provided psychological group intervention, but one group received treatment with nicotine gum and the other was given nortriptyline or placebo. The incidence of major depressive episodes was identified by the Inventory to Diagnose Depression, which was administered at follow-up assessments. Results: The 12-month incidence of major depression after treatment for smoking cessation was 14.1{\%} (N=43). Multiple logistic regression analyses indicated that history of depression, baseline Beck Depression Inventory score, college education, and age at smoking initiation were significant predictors of major depression after treatment. Abstinence at the end of treatment did not significantly predict major depression. Conclusions: Patients who achieved abstinence from smoking showed a risk of developing depressive episodes similar to those who failed to achieve abstinence. As expected, patients who had a history of depression were more likely to experience depressive episodes after treatment for smoking cessation. The 12-month incidence of major depression in this study group was higher than that observed in the general population, but reasons for the elevation were not clear.",
author = "Tsoh, {Janice Y.} and Humfleet, {Gary L.} and Mu{\~n}oz, {Ricardo F.} and Reus, {Victor I.} and Hartz, {Diane T.} and Hall, {Sharon M.}",
year = "2000",
month = "3",
doi = "10.1176/appi.ajp.157.3.368",
language = "English (US)",
volume = "157",
pages = "368--374",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "3",

}

TY - JOUR

T1 - Development of major depression after treatment for smoking cessation

AU - Tsoh, Janice Y.

AU - Humfleet, Gary L.

AU - Muñoz, Ricardo F.

AU - Reus, Victor I.

AU - Hartz, Diane T.

AU - Hall, Sharon M.

PY - 2000/3

Y1 - 2000/3

N2 - Objective: Case studies suggest cigarette abstinence may precipitate a major depressive episode. This study examined the incidence and predictors of major depression in the 12 months after treatment for smoking cessation. Method: Participants (N=304, 172 women) were recruited from two trials of smoking cessation. Both trials provided psychological group intervention, but one group received treatment with nicotine gum and the other was given nortriptyline or placebo. The incidence of major depressive episodes was identified by the Inventory to Diagnose Depression, which was administered at follow-up assessments. Results: The 12-month incidence of major depression after treatment for smoking cessation was 14.1% (N=43). Multiple logistic regression analyses indicated that history of depression, baseline Beck Depression Inventory score, college education, and age at smoking initiation were significant predictors of major depression after treatment. Abstinence at the end of treatment did not significantly predict major depression. Conclusions: Patients who achieved abstinence from smoking showed a risk of developing depressive episodes similar to those who failed to achieve abstinence. As expected, patients who had a history of depression were more likely to experience depressive episodes after treatment for smoking cessation. The 12-month incidence of major depression in this study group was higher than that observed in the general population, but reasons for the elevation were not clear.

AB - Objective: Case studies suggest cigarette abstinence may precipitate a major depressive episode. This study examined the incidence and predictors of major depression in the 12 months after treatment for smoking cessation. Method: Participants (N=304, 172 women) were recruited from two trials of smoking cessation. Both trials provided psychological group intervention, but one group received treatment with nicotine gum and the other was given nortriptyline or placebo. The incidence of major depressive episodes was identified by the Inventory to Diagnose Depression, which was administered at follow-up assessments. Results: The 12-month incidence of major depression after treatment for smoking cessation was 14.1% (N=43). Multiple logistic regression analyses indicated that history of depression, baseline Beck Depression Inventory score, college education, and age at smoking initiation were significant predictors of major depression after treatment. Abstinence at the end of treatment did not significantly predict major depression. Conclusions: Patients who achieved abstinence from smoking showed a risk of developing depressive episodes similar to those who failed to achieve abstinence. As expected, patients who had a history of depression were more likely to experience depressive episodes after treatment for smoking cessation. The 12-month incidence of major depression in this study group was higher than that observed in the general population, but reasons for the elevation were not clear.

UR - http://www.scopus.com/inward/record.url?scp=0034061482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034061482&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.157.3.368

DO - 10.1176/appi.ajp.157.3.368

M3 - Article

C2 - 10698811

AN - SCOPUS:0034061482

VL - 157

SP - 368

EP - 374

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 3

ER -